Synthesis of Silica-Coated Magnetic Hydroxyapatite Composites for Drug Delivery Applications
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIE
- 저널
- JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY19(4) · pp.1951 · 2019
- 피인용
- Web of Science 18
- JCR IF
- JCR 2018 1.093
- ISSN
- 1533-4880
저자
- Thenmozhi, Rajarathinam제1저자부경대학교, Ctr Marine Integrated Biomed Technol Plus BK21, KO
- Moorthy, Madhappan Santha제1저자부경대학교, Marine Integrated Bion Res Ctr, KO
- 자야하만시바구루부산대학교, 공과대학, 화공생명공학과, KO
- Manivasagan, Panchanathan부경대학교, Marine Integrated Bion Res Ctr, KO
- Bharathiraja, Subramanian부경대학교, Marine Integrated Bion Res Ctr, KO
- Oh, Yun-Ok부경대학교, Marine Integrated Bion Res Ctr, KO
- Oh, Junghwan교신저자부경대학교, Marine Integrated Bion Res Ctr, KO
초록
We have prepared a core-shell magnetic silica-coated hydroxyapatite, Fe3O4@SiO2@HAp composite materials for pH-responsive drug delivery applications. Captopril (Cap) and ibuprofen (Ibu) were chosen as model hydrophilic and hydrophobic drugs, respectively. The drugs were encapsulated into the Fe3O4@SiO2@HAp composite via electrostatic interactions with existing amine and carboxylic acid groups during calcium phosphate shell formation. The formation of calcium phosphate shell not only protects the encapsulated drugs from leaching but also controls the release rate of drugs from the composite system depending on various pH conditions. We have tested the release behavior of Cap and Ibu drugs under different pH conditions such as neutral pH (pH 7.4) and acidic pH (pH 5.0), respectively. The study result reveals that the synthesized Fe3O4@SiO2@HAp composite is suitable for release of both water soluble and water insoluble drugs based on a pH-responsive controlled manner.
키워드
Iron OxideSilica CoatingHydroxyapatiteDrug DeliveryCalcium PhosphateIRON-OXIDE NANOPARTICLESMESOPOROUS SILICACARBON NANOTUBESRELEASESYSTEMFUNCTIONALIZATIONPROGRESSSMART
식별자
- WoS UID
- 000451787200008



로그인
연구물 목록으로